Atıf Formatları
Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. EREK TOPRAK Et Al. , "Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment," MEDICAL SCIENCE MONITOR , vol.22, pp.1232-1237, 2016

EREK TOPRAK, A. Et Al. 2016. Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment. MEDICAL SCIENCE MONITOR , vol.22 , 1232-1237.

EREK TOPRAK, A., Ozlu, E., Ustunbas, T. K. , Yalcinkaya, E., SÖĞÜT, S., & KARADAĞ, A. S. , (2016). Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment. MEDICAL SCIENCE MONITOR , vol.22, 1232-1237.

EREK TOPRAK, AYBALA Et Al. "Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment," MEDICAL SCIENCE MONITOR , vol.22, 1232-1237, 2016

EREK TOPRAK, AYBALA E. Et Al. "Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment." MEDICAL SCIENCE MONITOR , vol.22, pp.1232-1237, 2016

EREK TOPRAK, A. Et Al. (2016) . "Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment." MEDICAL SCIENCE MONITOR , vol.22, pp.1232-1237.

@article{article, author={AYBALA EREK TOPRAK Et Al. }, title={Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment}, journal={MEDICAL SCIENCE MONITOR}, year=2016, pages={1232-1237} }